A miniaturized assay for influenza neuraminidase-inhibiting antibodies utilizing reverse genetics-derived antigens
about
Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza virusesA contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virusEfficacy of influenza vaccination and tamifluĀ® treatment--comparative studies with Eurasian Swine influenza viruses in pigsExpression and Characterization of Recombinant, Tetrameric and Enzymatically Active Influenza Neuraminidase for the Setup of an Enzyme-Linked Lectin-Based AssayA pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizationsCross-protection against European swine influenza viruses in the context of infection immunity against the 2009 pandemic H1N1 virus: studies in the pig model of influenza.Comparability of neuraminidase inhibition antibody titers measured by enzyme-linked lectin assay (ELLA) for the analysis of influenza vaccine immunogenicityInfluenza Neuraminidase Subtype N1: Immunobiological Properties and Functional Assays for Specific Antibody Response.Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays.Inactivated seasonal influenza vaccines increase serum antibodies to the neuraminidase of pandemic influenza A(H1N1) 2009 virus in an age-dependent manner.Cross-protection between antigenically distinct H1N1 swine influenza viruses from Europe and North America.Revisiting the 1976 "swine flu" vaccine clinical trials: cross-reactive hemagglutinin and neuraminidase antibodies and their role in protection against the 2009 H1N1 pandemic virus in mice.The 2009 pandemic H1N1 virus induces anti-neuraminidase (NA) antibodies that cross-react with the NA of H5N1 viruses in ferretsAn open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults.Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice.A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virusThe consortium for the standardization of influenza seroepidemiology (CONSISE): a global partnership to standardize influenza seroepidemiology and develop influenza investigation protocols to inform public health policy.Prior infection of pigs with a recent human H3N2 influenza virus confers minimal cross-protection against a European swine H3N2 virusWorkshop report: Immunoassay standardisation for "universal" influenza vaccines.Measurement of enzymatic activity and specificity of human and avian influenza neuraminidases from whole virus by glycoarray and MALDI-TOF mass spectrometry.Serologic assays for influenza surveillance, diagnosis and vaccine evaluation.Optimization of an enzyme-linked lectin assay suitable for rapid antigenic characterization of the neuraminidase of human influenza A(H3N2) viruses.An Innovative Pseudotypes-Based Enzyme-Linked Lectin Assay for the Measurement of Functional Anti-Neuraminidase Antibodies.Influenza neuraminidase.Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines.Impact of Adjuvants on the Immunogenicity and Efficacy of Split-Virion H7N9 Vaccine in Ferrets.Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination.Development of neuraminidase subtype-specific reference antisera by recombinant protein expressed in baculovirus.The immune correlates of protection for an avian influenza H5N1 vaccine in the ferret model using oil-in-water adjuvants.Correlates of vaccine protection from influenza and its complications.Immunological assessment of influenza vaccines and immune correlates of protection.Influenza A virus hemagglutinin specific antibodies interfere with virion neuraminidase activity via two distinct mechanisms.Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay.Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.Heterologous prime-boost vaccination with H3N2 influenza viruses of swine favors cross-clade antibody responses and protection.NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?Immunogenicity and Protection Against Influenza H7N3 in Mice by Modified Vaccinia Virus Ankara Vectors Expressing Influenza Virus Hemagglutinin or Neuraminidase.Complementary assays helping to overcome challenges for identifying neuraminidase inhibitorsAS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization
P2860
Q24615003-76E85377-A0D8-4F66-A0AD-FB5BD4124D8CQ27316330-9D818C4B-9755-4222-A43F-0CF11FDF2ADEQ28486415-52F6F74E-BA8C-4529-BC35-D5A6975B6732Q28547305-264EFBEC-5982-478D-B59F-1B52A89BADFEQ28749671-F9EED7BB-E55E-435F-92B6-4CB5C2DB0C1FQ30379517-FE2B4EC1-B41F-4612-B1C3-EB0C6A267526Q30382921-1AA60148-D7BD-4EC2-860F-3B939080C3A1Q30386612-AB2A618B-9DA8-4780-8576-183FA114D5C7Q30390818-F5F6C609-D69E-42B0-B0E2-8ADFCFB2BEECQ30395315-F6BDA35B-567A-4970-BA03-2CFDEC6C6D5AQ30399499-C5FC6D9A-F81A-4358-A9C6-5D18CDE6CA69Q30407834-583850AD-4E13-4ECD-A8AE-AA05C397BCE6Q30413023-1B311EAE-F2DA-4751-9856-8C994986A0B4Q30414282-5B9E5B19-B058-4296-949C-A3181EE3FF13Q30418452-10B911A5-46C3-40C7-92DF-9A4C6268FF9CQ30420210-03A9326B-3A9C-4271-9D2B-3A8B014CD773Q30425378-76178A3E-318B-48F9-AB77-90B8075A1243Q30428962-FF17C24E-4B93-49D2-B453-F4C60E810930Q33619871-2A09E544-2D17-4ED5-AAB0-EAF7A4BB632FQ33955610-54435DD0-B41F-404D-88BF-68308468A2FDQ34194336-10EE86EB-40D5-420C-AF68-F062FC2568E0Q35235777-E0F4E65A-49ED-4B96-8D33-DE3F8E0C3E31Q35744237-9BC78833-4B00-4B7C-B9BC-01E5C6F6B708Q35791130-F8FC925F-8E15-49DF-94D6-D297F7086C12Q36075789-7AD02FEE-E367-4167-AD42-EC799FEEE867Q36139178-3FC67042-6578-434E-8F48-5C40DB5E0C7DQ36306922-26B0A8FF-9B91-463C-B702-8294EDBB08EAQ36606800-B66F6119-B570-47DB-9AE5-B3D690E809E1Q37738010-95D2DA0A-C235-4F65-AB19-1EB92E70FD80Q37976539-B9B07043-DD1A-4ABF-BEC7-F31C87BF9BBAQ38105339-0B1276FE-E31A-4AB6-A2AA-A87329FC9E98Q40459715-5A27235B-7A23-4B29-8244-AA0E1FBB031BQ40523208-02FB7F45-8A44-4FA4-AF62-13AC1F36286DQ41347626-A81C86ED-4565-422E-A233-121A4394D0FBQ46060826-275E6A49-C891-4F9F-B300-7EEB736D617DQ52609074-690BE01A-45C5-4A88-868B-F756ECB7B52DQ52620757-A87177D7-B476-448C-9AA3-E8E70EDF7CEFQ57010547-88A4630D-4509-4989-AC5A-6F00E1E931BBQ57299518-967A4741-AA8B-42B9-BFD9-F46C177AB5F9
P2860
A miniaturized assay for influenza neuraminidase-inhibiting antibodies utilizing reverse genetics-derived antigens
description
2009 nĆ® lÅ«n-bĆ»n
@nan
2009 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« ÕÕ„ÕŗÕæÕ„Õ“Õ¢Õ„ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
2009 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Õ½Õ„ÕŗÕæÕ„Õ“Õ¢Õ„ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
2009幓ć®č«ę
@ja
2009幓å¦ęÆęē«
@wuu
2009幓å¦ęÆęē«
@zh-cn
2009幓å¦ęÆęē«
@zh-hans
2009幓å¦ęÆęē«
@zh-my
2009幓å¦ęÆęē«
@zh-sg
2009幓åøč”ęē«
@yue
name
A miniaturized assay for influ ...... erse genetics-derived antigens
@ast
A miniaturized assay for influ ...... erse genetics-derived antigens
@en
type
label
A miniaturized assay for influ ...... erse genetics-derived antigens
@ast
A miniaturized assay for influ ...... erse genetics-derived antigens
@en
prefLabel
A miniaturized assay for influ ...... erse genetics-derived antigens
@ast
A miniaturized assay for influ ...... erse genetics-derived antigens
@en
P2860
P3181
P1476
A miniaturized assay for influ ...... erse genetics-derived antigens
@en
P2093
Timothy M Straight
P2860
P304
P3181
P356
10.1111/J.1750-2659.2009.00094.X
P407
P577
2009-09-01T00:00:00Z